文献速递头颈甲状腺与浅表CTUS

基于CT的Node-RADS评估甲状腺乳头状癌颈部区域淋巴结转移的表现

Performance of CT-based Node-RADS for assessing cervical regional lymph node metastasis in papillary thyroid carcinoma.
PubMed 文献 · Eur J Radiol · 2025-12-01

回顾性分析191例甲状腺乳头状癌患者共300枚淋巴结(204枚转移、96枚良性),评估基于增强CT的Node-RADS评分诊断淋巴结转移的表现;中央区与侧区淋巴结分别在评分≥2和≥4时表现最佳,AUC为0.772和0.756;Node-RADS评分联合超声诊断效率最佳,中央区AUC 0.846、侧区AUC 0.872。

要点

  • 中央区淋巴结Node-RADS评分≥2时诊断表现最佳,AUC为0.772。
  • 侧区淋巴结Node-RADS评分≥4时诊断表现最佳,AUC为0.756。
  • Node-RADS评分联合超声诊断效率最佳,中央区AUC 0.846、侧区AUC 0.872。

核心结论

  • Node-RADS增强CT评分系统提供了标准化的淋巴结转移评估。
  • Node-RADS增强CT评分联合超声可提升预测准确性。
  • 评分1和2的淋巴结转移率在淋巴结水平为15.32%至35.48%,作者认为需在今后研究中验证。

研究设计与样本

  • 回顾性分析191例甲状腺乳头状癌患者(男61例、女130例,平均年龄45.37±13.22岁),均行术前增强CT、超声检查及淋巴结清扫。
  • 共评估300枚淋巴结,其中转移204枚、良性96枚。
  • 采用Node-RADS增强CT评分系统进行分析,计算AUC、敏感度、特异度及约登指数。

诊断标准与关键数值

  • 淋巴结水平中央区淋巴结Node-RADS增强CT评分≥2时诊断表现最佳,AUC为0.772。
  • 淋巴结水平侧区淋巴结Node-RADS增强CT评分≥4时诊断表现最佳,AUC为0.756。
  • Node-RADS增强CT评分为淋巴结转移的独立预测因子,OR=2.41,p<0.05。
  • Node-RADS增强CT评分联合超声诊断效率最佳,中央区AUC为0.846、侧区AUC为0.872(Delong检验p<0.05)。

局限性

  • 评分1和2的淋巴结转移率在淋巴结水平为15.32%至35.48%,作者认为需在今后研究中验证。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

英文原文(摘要)· 点击展开

OBJECTIVES: The Node Reporting and Data System (Node-RADS) score system was recently proposed to better characterize lymph node metastasis (LNM). The study aimed to explore the diagnostic performance of Node-RADS score system for predicting LNM on CECT (contrast-enhanced CT) scans in patients with papillary thyroid carcinoma (PTC).

METHODS: In total, 191 PTC patients (61 males and 130 females, average age: 45.37 ± 13.22 years), who underwent preoperative CECT, US examinations and lymph nodes (LNs) dissection, were retrospectively analyzed through Node-RADS CECT score system. Moreover, the area under the curve (AUC), sensitivity, specificity, and Youden's index were calculated for Node-RADS CECT score and individual criteria.

RESULTS: Overall, 191 patients with a total of 300 LNs (204 metastatic and 96 benign) were assessed. At the LNs level, best performance was found for Node-RADS CECT score ≥ 2 and ≥ 4 of central LNs and lateral LNs (AUC: 0.772 and 0.756), respectively. Node-RADS CECT score was shown to be an independent predictor of LNM (odds ratio [OR] = 2.41, p < 0.05). Among all criteria, combined with Node-RADS CECT score and US achieved the best diagnostic efficiency in evaluation of LNM, with AUCs of 0.846 in central group and 0.872 in lateral group (Delong test: p < 0.05).

CONCLUSIONS: The Node-RADS CECT score system provides a standardized LNM assessment. Combined Node-RADS CECT score and US would lead to an enhancement in predictive accuracy. Whereas, the rates of LNM ranged from 15.32% to 35.48% at the node level for score 1 and 2, which should be validated in the future research.

来源:Eur J Radiol,查看原文。版权归原作者所有。

引用

  1. Xiang Y, Huang D, Zhang Y, et al. Performance of CT-based Node-RADS for assessing cervical regional lymph node metastasis in papillary thyroid carcinoma. Eur J Radiol. 2025. PMID: 41343960. doi:10.1016/j.ejrad.2025.112593

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。